WuXi AppTec Co., Ltd. (603259)

Overview

Founded in 2000 and headquartered in Shanghai, WuXi AppTec Co., Ltd. stands as a beacon in the pharmaceutical and biotechnological sectors, primarily serving in the People's Republic of China, the United States, Europe, and other international markets. This investment holding company has etched its name as a leader in providing comprehensive research and manufacturing services tailored to facilitate the discovery, development, and manufacturing of a wide spectrum of small molecule drugs and advanced therapies. Operating through its six distinct segments, namely WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others, WuXi AppTec has established a formidable presence in its domain. Its services span across contract research, development, and manufacturing organization domains, covering new drug development from conceptualization to commercialization across a varied range of synthetic molecular modalities.

Products and Services

• Contract Research, Development, and Manufacturing Organization Services

  WuXi AppTec offers an extensive portfolio of services encompassing the entire lifecycle of new drug development. This includes discovery, development, and manufacturing services for small molecules, oligonucleotides, peptides, and complex conjugates. The company's approach integrates both the chemical and biological aspects of drug development to cater to the pharmaceutical and biotech industries effectively.

• Biology Services and Solutions

  The company delivers robust biology services and solutions, supporting projects from target discovery through to candidate selection and clinical trials. These services are designed to be both stand-alone and integrated, offering a comprehensive support system for new drug discovery and development.

• Drug and Medical Device Testing Services

  WuXi AppTec provides a wide range of testing services encompassing preclinical and clinical trials. This includes extensive pharmacology, toxicology, and safety evaluation research services aimed at ensuring the efficacy and safety of new medical interventions.

• Integrated End-to-End Solution for Cell and Gene Therapies

  To accelerate the market introduction of cell and gene therapies, the company provides an integrated end-to-end solution. This vertical enables seamless progression from research to commercialization, ensuring that these pioneering treatments reach patients faster.

• Drug Discovery Services

  Catering specifically to pharmaceutical and biotech clients, WuXi AppTec's drug discovery services are designed to streamline the process of new therapeutic discoveries. By leveraging its expertise and resources, the company positions itself as a critical ally in the drug discovery process.

• Consulting Services for Combinatorial Chemistry and Pharmaceuticals

  WuXi AppTec extends its expertise into consulting services, focused on combinatorial chemistry and pharmaceuticals. This service is aimed at providing strategic insights and solutions to overcome the complex challenges in drug development.

• Software Development and Database Services

  Understanding the pivotal role of technology in pharmaceutical research, the company has ventured into developing computer software and databases. These technological tools are crafted to bolster research efficiency and data management for its clients.